Know your NICU nutrition: The importance of appropriate nutrition in the NICU
Type: Prolacta in the News
Topic(s): Bronchopulmonary Dysplasia (BPD) Late-Onset Sepsis Necrotizing Entercolitis (NEC) Parents Retinopathy of Prematurity (ROP)
Guided by evidence-based care in the use of human milk-based nutrition in the NICU: Learning from the past
Type: Prolacta in the News
Topic(s): Quality & Safety
Sinai Chicago is first safety net NICU to address health inequity gap by adopting an EHMD
Type: Prolacta in the News
Topic(s): Company Feeding Intolerance Mortality
Human breastmilk fortifiers may ward off eye disease in premature babies, finds Prolacta-backed study
Type: Prolacta in the News
Topic(s): Retinopathy of Prematurity (ROP)
Four studies showed Prolacta Bioscience’s 100% human milk-based fortifiers reduced retinopathy of prematurity (ROP) in premature infants
Type: Press Releases
Topic(s): Retinopathy of Prematurity (ROP)
Baby Crew achieves healthy growth with Prolacta's fortifiers
Type: Parent Stories
Topic(s): 22-27 weeks (extremely premature) Parents
Gloria Crockett, senior director of quality
Type: Employee Stories
Topic(s): Company Quality & Safety
Use of an exclusive human milk diet in preterm infants to lower healthcare costs – short-term and long-term perspectives
Type: Prolacta in the News
Topic(s): Cost Savings / Cost Effectiveness Long-Term outcomes Pasteurization
Prolacta Bioscience provides update on latest SARS-CoV-2 data and continued safety of its human milk-based nutritional products
Type: Press Releases
Topic(s): Quality & Safety
